Surrogate markers in clinical studies: problems solved or created?

PubWeight™: 1.28‹?› | Rank: Top 10%

🔗 View Article (PMID 16797400)

Published in Am J Kidney Dis on July 01, 2006

Authors

Braden Manns, William F Owen, Wolfgang C Winkelmayer, P J Devereaux, Marcello Tonelli

Articles by these authors

Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47

CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ (2010) 28.70

Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95

Effects of computerized clinical decision support systems on practitioner performance and patient outcomes: a systematic review. JAMA (2005) 23.44

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ (2009) 22.18

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med (2009) 21.74

Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet (2008) 13.15

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med (2009) 12.16

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol (2009) 11.80

The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science (2010) 9.61

Randomized trials stopped early for benefit: a systematic review. JAMA (2005) 8.43

Relation between kidney function, proteinuria, and adverse outcomes. JAMA (2010) 8.26

Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet (2015) 7.99

Age and association of kidney measures with mortality and end-stage renal disease. JAMA (2012) 7.20

CONSORT 2010 Explanation and Elaboration: Updated guidelines for reporting parallel group randomised trials. J Clin Epidemiol (2010) 7.04

Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. JAMA (2012) 6.26

The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. Kidney Int (2011) 6.21

Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition. Lancet (2015) 6.13

Effectiveness of quality improvement strategies on the management of diabetes: a systematic review and meta-analysis. Lancet (2012) 5.65

Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts. Kidney Int (2011) 5.47

Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: a randomized controlled trial. JAMA (2007) 5.31

A Trial of Wound Irrigation in the Initial Management of Open Fracture Wounds. N Engl J Med (2015) 5.28

Treatment and outcomes of acute coronary syndromes in India (CREATE): a prospective analysis of registry data. Lancet (2008) 5.27

The relationship between visit-to-visit variability in systolic blood pressure and all-cause mortality in the general population: findings from NHANES III, 1988 to 1994. Hypertension (2011) 5.14

Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis. Lancet (2012) 5.10

Validity of International Classification of Diseases, Ninth Revision, Clinical Modification Codes for Acute Renal Failure. J Am Soc Nephrol (2006) 4.95

Recommendations on screening for breast cancer in average-risk women aged 40-74 years. CMAJ (2011) 4.68

Association between postoperative troponin levels and 30-day mortality among patients undergoing noncardiac surgery. JAMA (2012) 4.58

Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials. CMAJ (2004) 4.53

A systematic evaluation of the quality of meta-analyses in the critical care literature. Crit Care (2005) 4.51

Internet versus mailed questionnaires: a randomized comparison (2). J Med Internet Res (2004) 4.45

Off-pump or on-pump coronary-artery bypass grafting at 30 days. N Engl J Med (2012) 4.32

Systematic review and meta-analysis: renal safety of tenofovir disoproxil fumarate in HIV-infected patients. Clin Infect Dis (2010) 4.28

Effects of off-pump and on-pump coronary-artery bypass grafting at 1 year. N Engl J Med (2013) 4.27

An observational study of orthopaedic abstracts and subsequent full-text publications. J Bone Joint Surg Am (2002) 4.25

Health Effects of Overweight and Obesity in 195 Countries over 25 Years. N Engl J Med (2017) 3.90

A new 'mechanistic-practical" framework for designing and interpreting randomized trials. J Clin Epidemiol (2008) 3.75

When laboratories report estimated glomerular filtration rates in addition to serum creatinines, nephrology consults increase. Kidney Int (2009) 3.70

The safety of addition of nitrous oxide to general anaesthesia in at-risk patients having major non-cardiac surgery (ENIGMA-II): a randomised, single-blind trial. Lancet (2014) 3.70

Benefits and harms of statin therapy for persons with chronic kidney disease: a systematic review and meta-analysis. Ann Intern Med (2012) 3.62

Physicians' and patients' choices in evidence based practice. BMJ (2002) 3.57

CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. Int J Surg (2011) 3.57

Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study. Circulation (2004) 3.56

GRADE guidelines 6. Rating the quality of evidence--imprecision. J Clin Epidemiol (2011) 3.54

Recommendations on screening for type 2 diabetes in adults. CMAJ (2012) 3.51

Oral phosphate binders in patients with kidney failure. N Engl J Med (2010) 3.42

Barriers to full-text publication following presentation of abstracts at annual orthopaedic meetings. J Bone Joint Surg Am (2003) 3.36

Patients at the center: in our practice, and in our use of language. ACP J Club (2004) 3.32

Recommendations on screening for cervical cancer. CMAJ (2013) 3.32

Cardiac Complications in Patients Undergoing Major Noncardiac Surgery. N Engl J Med (2015) 3.31

Randomized controlled trials of surgical interventions. Ann Surg (2010) 3.30

Intensive and Standard Blood Pressure Targets in Patients With Type 2 Diabetes Mellitus: Systematic Review and Meta-analysis. Arch Intern Med (2012) 3.26

Quality of care in for-profit and not-for-profit nursing homes: systematic review and meta-analysis. BMJ (2009) 3.22

Early recognition and prevention of chronic kidney disease. Lancet (2010) 3.19

Internal fixation compared with arthroplasty for displaced fractures of the femoral neck. A meta-analysis. J Bone Joint Surg Am (2003) 3.14

Association between glycemic control and adverse outcomes in people with diabetes mellitus and chronic kidney disease: a population-based cohort study. Arch Intern Med (2011) 3.13

Effect of early surgery after hip fracture on mortality and complications: systematic review and meta-analysis. CMAJ (2010) 3.13

Prognostic value of troponin T and I among asymptomatic patients with end-stage renal disease: a meta-analysis. Circulation (2005) 3.10

Cost analysis of ongoing care of patients with end-stage renal disease: the impact of dialysis modality and dialysis access. Am J Kidney Dis (2002) 3.06

Change in the estimated glomerular filtration rate over time and risk of all-cause mortality. Kidney Int (2013) 3.05

A systematic review of the effect of nocturnal hemodialysis on blood pressure, left ventricular hypertrophy, anemia, mineral metabolism, and health-related quality of life. Kidney Int (2005) 3.03

Association between pulse pressure and mortality in patients undergoing maintenance hemodialysis. JAMA (2002) 2.98

Meta-analysis: erythropoiesis-stimulating agents in patients with chronic kidney disease. Ann Intern Med (2010) 2.97

Glomerular filtration rate, proteinuria, and the incidence and consequences of acute kidney injury: a cohort study. Lancet (2010) 2.95

Oral estrogen therapy in postmenopausal women is associated with loss of kidney function. Kidney Int (2008) 2.88

Hetastarch and bleeding complications after coronary artery surgery. Chest (2003) 2.87

Statins for improving renal outcomes: a meta-analysis. J Am Soc Nephrol (2006) 2.84

The comparative short-term effectiveness of iron dosing and formulations in US hemodialysis patients. Am J Med (2013) 2.77

Intensive care unit bed availability and outcomes for hospitalized patients with sudden clinical deterioration. Arch Intern Med (2012) 2.75

Comparative mortality risk of anemia management practices in incident hemodialysis patients. JAMA (2010) 2.71

Early mobilisation for patients following acute myocardiac infarction: a systematic review and meta-analysis of experimental studies. Int J Nurs Stud (2009) 2.69

Operative management of displaced femoral neck fractures in elderly patients. An international survey. J Bone Joint Surg Am (2005) 2.68

Nephrology visits and health care resource use before and after reporting estimated glomerular filtration rate. JAMA (2010) 2.61

Internet versus mailed questionnaires: a controlled comparison (2). J Med Internet Res (2004) 2.59

Clinical expertise in the era of evidence-based medicine and patient choice. ACP J Club (2002) 2.58

Improvements in long-term mortality after myocardial infarction and increased use of cardiovascular drugs after discharge: a 10-year trend analysis. J Am Coll Cardiol (2008) 2.58

Overview of the Alberta Kidney Disease Network. BMC Nephrol (2009) 2.58

Nocturnal hemodialysis does not improve overall measures of quality of life compared to conventional hemodialysis. Kidney Int (2008) 2.56

Is a pre-operative brain natriuretic peptide or N-terminal pro-B-type natriuretic peptide measurement an independent predictor of adverse cardiovascular outcomes within 30 days of noncardiac surgery? A systematic review and meta-analysis of observational studies. J Am Coll Cardiol (2009) 2.56

Users' guide to detecting misleading claims in clinical research reports. BMJ (2004) 2.55

Guidelines for the management of chronic kidney disease. CMAJ (2008) 2.54

Prevention of dialysis catheter malfunction with recombinant tissue plasminogen activator. N Engl J Med (2011) 2.48

Randomized clinical trials--removing unnecessary obstacles. N Engl J Med (2013) 2.43

Rates of treated and untreated kidney failure in older vs younger adults. JAMA (2012) 2.43

Efficacy of statins for primary prevention in people at low cardiovascular risk: a meta-analysis. CMAJ (2011) 2.40

The quality of randomized trial reporting in leading medical journals since the revised CONSORT statement. Contemp Clin Trials (2005) 2.40

Effect of fish oil supplementation on graft patency and cardiovascular events among patients with new synthetic arteriovenous hemodialysis grafts: a randomized controlled trial. JAMA (2012) 2.38

Mycophenolate mofetil for induction therapy of lupus nephritis: a systematic review and meta-analysis. Clin J Am Soc Nephrol (2007) 2.38

Systematic review of the impact of N-acetylcysteine on contrast nephropathy. Kidney Int (2004) 2.37

Association between LDL-C and risk of myocardial infarction in CKD. J Am Soc Nephrol (2013) 2.34

The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease. J Am Coll Cardiol (2004) 2.32

Estimate of the benefits of a population-based reduction in dietary sodium additives on hypertension and its related health care costs in Canada. Can J Cardiol (2007) 2.32

Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses? Int J Epidemiol (2008) 2.31

Weekend hospital admission, acute kidney injury, and mortality. J Am Soc Nephrol (2010) 2.30

Surgery for hip fractures: Does surgical delay affect outcomes? Indian J Orthop (2011) 2.30